Medivolve Inc. · OTC:MEDVF
Medivolve — Investor Presentation (June 2021)
36 slides from Medivolve's investor presentation, June 2021
Slide 1: Medivolve Investor Presentation
HEALTH TECH DISRUPTOR BUILT FOR TRANSFORMATION MEDIVOLVE. INVESTOR PRESENTATION.
Slide 2: Disclaimer
DISCLAIMER This presentation of Medivolve Inc. (“Medivolve” or the “Company”) is for informational purposes only and does not constitute an offer to buy, sell, issue or subscribe for, or the solicitation of an offer to buy, sell or issue, or subscribe for any securities of the Company. The in- forma
Slide 3: About Us and Our Future
ABOUT US AND OUR FUTURE. TICKERS NEO: MEDV 01 WHAT WE DO OTC: COPRF FRA: 34C1 Medivolve is a publicly traded healthcare company that seeks out disruptive technologies, ground-breaking innovations and exclusive partnerships to transform human health management. With a seasoned executive team and reno
Slide 4: Business Philosophy
BUSINESS PHILOSOPHY. TRANSFORM 02 BU ILT FOR TR A N S FOR M ATION We’re building a med-tech platform to not only change the way we approach global health crises, but the future OUR WHY of human health management. Born out of the Covid-19 pandemic and as the urgent need to address gaps in the nation’
Slide 5: Built for Transformation
BUILT FOR TRANSFORMATION We’re building a med-tech platform to not only change the way we approach global health crises, but the future of human health management. N EXT
Slide 6: Built for Transformation
BUILT FOR TRANSFORMATION. Out of our greatest times of crises comes opportunity, and the COVID-19 pandemic is no different. Forced to rethink, relearn and ultimately, reimagine a better way for our healthcare system, Medivolve was born out of this revolution, and is BUILT FOR TRANSFORMATION. For the
Slide 7: Flattening the Curve One Cube at a Time
COLLECTION SITES WHAT IT IS Wholly owned subsidiary Collection Sites has 37 COVID-19 testing sites across the U.S. Each site (or cube) is a complete and versatile solution for the ultra-high demand COVID-19 testing marketing in the U.S. The testing centers offer convenient access to rapid antibody a
Slide 8: Collection Sites: Complete and Versatile Solution
COLLECTION SITES A complete and versatile solution for the ultra-high demand COVID-19 testing marketing in the U.S. Wholly owned subsidiary Collection Sites has 37 COVID-19 testing sites across the U.S. Collection Sites provides quick and convenient COVID-19 testing in conjunction with a CLIA regist
Slide 9: $0 Out-Of-Pocket COVID-19 Testing
COLLECTION SITES $0 Out-Of-Pocket COVID-19 TESTING A Mission to Test America…. 09 Every Person, Every Week. Understanding the difficult situation that we are facing as a nation, an assembly of top companies in the industry have combined their knowledge and resources to help businesses create the saf
Slide 10: COVID-19 Testing: Antibody, RT-PCR & Swabs
COLLECTION SITES COVID-19 R A PID A N TIBODY BLOOD TE ST Antibody (Serology) tests look for SARS-CoV-2 IgM & IgG antibodies1 in the blood to determine if there was a past infection. A blood sample is taken with immediate results provided, but will also be sent to a lab for certified testing results.
Slide 11: COVID-19 Testing – How It Works
05 COVID-19 Testing – How It Works. Rapid Antibody Blood Test RT-PCR Test Antigen Test Finger Prick Remove protective cap from blue needle and 1. Samples are collected 1. Peel off aluminum foil pierce the tip of your finger. from the nose or throat of a 5x seal and rotate the swab patient using a sw
Slide 12: COVID-19 Testing: Quick Certified Results
06 COLLECTION SITES COVID-19 TESTING Quick Certified Results Accuracy A 95%-98% agreement of positive and negative results 12 Quick Results (rapid antibody test only) Preliminary results within 10 minutes after taking the test Certified lab results next day (subject to change based on volume) Certif
Slide 13: Expanding Our Portfolio of Pharmacy Acquisitions
WHAT IT IS Located in San Juan Capistrano, California, Marbella is an open-door retail pharmacy specializing in traditional MARBELLA PHARMACY medication and non-sterile compounded products, immunizations, and specialty and maintenance medica- tions. Marbella Pharmacy also provides no cost door-to-do
Slide 14: Reopening America: Medivolve x DailyPay
DAILY PAY WHAT IT IS DailyPay is an earned wage access platform. But the platform does so much more than give employees access to their earnings in real-time. The platform changes the way money moves between employer and employee, between merchant and shopper, between financial institution and custo
Slide 15: Create Healthier Lives
CREATE HEALTHIER LIVES Our model aims to create a full-circle healthcare solution that closes the gap between diagnosis and treatment. N EXT
Slide 16: Create Healthier Lives
CREATE HEALTHIER LIVES. We’re setting our sights on a longer-term vision because the real war is bigger than one pandemic. In the United States today, one person dies every 36 seconds from cardiovascular disease. There were 2 million more people diagnosed with cancer this year alone. And, over 34 mi
Slide 17: Medivolve and Marvel Diagnostics Complete First-Stage Clinical Testing
13 BLOWFISH WHAT IT IS BlowFISH is a simple, inexpensive, non-invasive, massively-deployable, rapid diagnostic or sentinel system for detecting respiratory illness and airborne viral threats. STRATEGIC GROWTH IMPERATIVE MEDIVOLVE AND Through this partnership, Medivolve is well positioned to deliver
Slide 18: BlowFISH: The Future Is Bright
14 BLOWFISH THE FUTURE IS BRIGHT. DIAGRAM OF INNOVATIVE BLOWFISH DEVICE IN USE Novel BlowFISH device that captures virus within Exhaled Breath Condensate (EBC).
Slide 19: Aditxt Immune Monitoring: Protective Immunity
ADITXTScoreTM WHAT IT IS Aditxt Therapeutics, Inc. (“Aditxt”) is a biotech innovation company with a mission to prolong life and enhance its quality by improving immune system health-specifically by developing technologies focused on immune reprogramming and monitoring. ADITXT IMMUNE MONITORING: STR
Slide 20: AditxtScore: The World Awaits
ADITXTScoreTM THE WORLD AWAITS. MONITORING AND REPROGRAMMING THE IMMUNE SYSTEM Using innovative technology developed by world leading How it works: Samples are collected and shipped to research institutions, AditxtScore Aditxt’s high-complexity CLIA-certified lab. provides personalized quantitative
Slide 21: AditxtScore Provides Vital Answers During Every Stage of the Pandemic
17 ADITXTScore TM AditxtScore Provides Vital Answers During TM Every Stage of the Pandemic (and Beyond). Have I been exposed? Am I developing antibodies in Do I have response to the vaccine? Is there evidence that I the virus? Is there evidence of an immune response? have developed Is the immune res
Slide 22: Reduce False Positives & Negatives
ADITXTScoreTM Reduce False Positives & Negatives. AditxtScore™ has 20-fold increased signal to noise ratio even at higher dilution Enhanced sensitivity for detection over background signal
Slide 23: Timely Evaluation of Response to Vaccines
19 ADITXTScoreTM Timely Evaluation of Response to Vaccines. Detects multiple antibodies to multiple antigens in a single test Has potential to incorporate additional targets (i.e. other viruses) in the same assay Detection of antibody levels before and after vaccination
Slide 24: Detection of Multiple Isotypes Against Multiple Antigens
ADITXTScoreTM Detection of Multiple Isotypes Against Multiple Antigens Increases Sensitivity & Specificity. Sensitivity/specificity using one antigen (RBD) Combined 3 antigens
Slide 25: Comprehensive Evaluation of T Cell Response
ADITXTScoreTM Comprehensive Evaluation of T Cell Response (v.2.0). Can detect multiple cytokines in a single test with higher sensitivity Determines and differentiates between various types of cellular & Humoral immune responses Simultaneous monitoring of cell activation and levels of cytokine relea
Slide 26: AditxtScore Immune Monitoring Protective Immunity Testing Solution
ADITXTScoreTM AditxtScoreTM Immune Monitoring is the Protective Immunity Testing Solution for… Lo re m i p s um d o lo r s i t am e t, co ns e c
Slide 27: Inspire the New Future of Healthcare
INSPIRE THE NEW FUTURE OF HEALTHCARE Lo re m i p s um d o lo r s i t am e t, co ns e c We are striving to achieve a continuity of care never seen before. N EXT
Slide 28: Inspire the New Future of Healthcare
INSPIRE THE NEW FUTURE OF HEALTHCARE. Our model aims to close the gap between diagnostic data and prescription drugs, bringing data-driven clinical decisioning in a way never seen before, powered by a singular, streamlined technology network. Our direct-to-patient strategy is supported by nearly 50
Slide 29: Medivolve Acquires Industry-Leading Myosin App
WHAT IT IS MYOSIN APP The electronic health record platform is designed to improve patient care and increase collaboration with clinicians through an efficient, cloud-based system. The app streamlines patient intake forms and delivers medical reports through personal- ized patient portals. Clinical
Slide 30: Meet the Team
MEET THE TEAM We have the right tools, team, and information, and today we are laying the foundation to ultimately INSPIRE THE NEW FUTURE of human health management. The opportunity before us is bigger than any one innovation. Together with a new management team, strategic partners, and a purpose-dr
Slide 31: Medivolve Officers
MEDIVOLVE OFFICERS. 31 DOUG SOMMERVILLE DR. BEVERLEY DANIEL BAIZAK WEN YE DIRECTOR RICHARDSON DIRECTOR EXECUTIVE CHAIRMAN Learn more. Learn more. Learn more. DIRECTOR Learn more.
Slide 32: Medivolve Directors
MEDIVOLVE DIRECTORS. 32 DAVID PREINER DEBORAH BATTISTON AARON ATIN WEN YE CEO CFO Corporate Secretary EXECUTIVE CHAIRMAN Learn more. Learn more. Learn more. Learn more.
Slide 33: Medivolve Advisors
29 MEDIVOLVE 33 ADVISORS. DR. GLENN DR. JOESEPH DR. LAWRENCE DR. PAULO COPELAND SUGERMAN STEINMAN IGLESSIAS ADVISOR ADVISOR ADVISOR ADVISOR Learn more. Learn more. Learn more. Learn more.
Slide 34: Strategic Advisors
STRATEGIC ADVISORS. 34 MICHAEL MCCARTHY JIM ROGERS MIKE MANCIAS RICHARD DOLAN ADVISOR ADVISOR ADVISOR ADVISOR Learn more. Learn more. Learn more. Learn more.
Slide 35: Disclaimer - Rescission Rights
DISCLAIMER - RECISION RIGHTS In certain circumstances, purchasers resident in certain provinces of Canada are provided with a remedy for rescission or damages, or both, in addition to any other rights they may have at law, where an offering memorandum (such as this presentation) and any amendment to
Slide 36: Thank You
medivolve THANK YOU